Pds Biotechnology Corporation (PDSB)

07:09 AM

What analysts say about PDS Biotechnology Corporation stockOutstanding trading profits - PrintWeekIndia

07:09 AM

03:45 AM

What makes PDS Biotechnology Corporation stock price move sharplyReal Time Alert Service - Newser

03:45 AM

01:07 AM

Is PDS Biotechnology Corporation stock a good hedge against inflationSuperior risk-adjusted returns - jammulinksnews.com

01:07 AM

Jul 23, 2025

PDS Biotechnology Corporation Stock Analysis and ForecastDynamic profit expansion - Autocar Professional

Jul 23, 2025

Jul 22, 2025

PDS Biotechnology Publishes Versamune® HPV Abstracts at ASCO - MSN

Jul 22, 2025

Jul 22, 2025

What drives PDS Biotechnology Corporation stock priceFree Stock Movement Tracking - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is PDS Biotechnology Corporation a good long term investmentFree High-Return Strategy Alerts - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

How PDS Biotechnology Corporation stock performs during market volatilityHigh Yield Stock Selection - Newser

Jul 22, 2025

Jul 15, 2025

Why PDS Biotechnology Corporation stock attracts strong analyst attentionFree Stock Market Knowledge Sharing - Newser

Jul 15, 2025

Jul 11, 2025

PDS Biotechnology stock advances as Phase 2 trial meets expansion criteria - Investing.com Nigeria

Jul 11, 2025

Jul 11, 2025

PDS Biotechnology completes recruitment for stage one of colorectal cancer trial - Yahoo Finance

Jul 11, 2025

Jul 10, 2025

PDS Biotechnology Corporation Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results - MarketScreener

Jul 10, 2025

Jul 10, 2025

PDS Biotechnology stock rises after trial meets criteria for expansion By Investing.com - Investing.com Nigeria

Jul 10, 2025

Jul 10, 2025

PDS Biotechnology stock rises after trial meets criteria for expansion - Investing.com Australia

Jul 10, 2025

Jul 10, 2025

PDS Biotech's PDS01ADC: A Breakthrough in Cytokine Therapy for Metastatic Colorectal Cancer - AInvest

Jul 10, 2025

Jul 10, 2025

PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results - The Manila Times

Jul 10, 2025

Jul 10, 2025

PDS Biotech Achieves Crucial Phase 2 Milestone: Colorectal Cancer Drug Shows Promising Early Results - Stock Titan

Jul 10, 2025

Jul 01, 2025

PDS Biotechnology (PDSB) Retains "Buy" Rating with Price Target Unchanged | PDSB Stock News - GuruFocus

Jul 01, 2025

Jun 18, 2025

PDSB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jun 18, 2025

Jun 17, 2025

Transcript : PDS Biotechnology CorporationSpecial Call - MarketScreener

Jun 17, 2025

Jun 17, 2025

PDS Biotechnology holds a conference call - TipRanks

Jun 17, 2025

Jun 14, 2025

PDS Biotechnology (NASDAQ:PDSB) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 14, 2025

Jun 14, 2025

HC Wainwright Issues Pessimistic Estimate for PDSB Earnings - Defense World

Jun 14, 2025

Jun 13, 2025

PDS Biotechnology Co. (NASDAQ:PDSB) Shares Sold by Millennium Management LLC - Defense World

Jun 13, 2025

Jun 13, 2025

Two Sigma Investments LP Raises Stock Holdings in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

Jun 13, 2025